153 results
Page 2 of 8
6-K
EX-99.2
fcq48mu u745tn
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am
6-K
EX-99.1
l4d5h91egqrp5s 0ptn
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am
6-K
EX-99.1
mp4pie1s
5 Jul 22
BELLUS Health to Participate in the William Blair Biotech Focus Conference
7:00am
6-K
EX-99.1
xubyo jtcw
1 Jun 22
BELLUS Health to Participate in the Jefferies Healthcare Conference
7:00am
6-K
EX-99.1
kqgso8j76x
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
EX-99.2
q39pjjf1cx3ajgx3v
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
5fj1m69r8jvb8xwbu
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
61ifhf afnd0a2jx1qh
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
iu9xuz yf
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
99nbyw
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
uy807m
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
SUPPL
piy5ferjr
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
skqw7
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
nb2dnpfyxb70r279uo
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.2
m8npik10 z94
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
yutmjcmcfb6yplsfx3a
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
hl4j oo0miugarr
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.2
cv26fv9 0bpzqvufj
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.1
wmy hcwfn
10 Nov 21
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
EX-99.1
v5ktwu1uc
1 Nov 21
Bellus Health Inc. 6-K
7:00am